000 02925cam a2200421Mu 4500
001 9781315102917
003 FlBoTFG
005 20220509192931.0
006 m d
007 cr cnu---unuuu
008 191207s2019 xx o 000 0 eng d
040 _aOCoLC-P
_beng
_cOCoLC-P
020 _a9781351593519
020 _a135159351X
020 _a9781315102917
_q(electronic bk.)
020 _a1315102919
_q(electronic bk.)
020 _a9781351593502
_q(electronic bk. : EPUB)
020 _a1351593501
_q(electronic bk. : EPUB)
020 _a9781351593496
_q(electronic bk. : Mobipocket)
020 _a1351593498
_q(electronic bk. : Mobipocket)
035 _a(OCoLC)1130038559
035 _a(OCoLC-P)1130038559
050 4 _aRS200
072 7 _aMED
_x071000
_2bisacsh
072 7 _aMMG
_2bicssc
082 0 4 _a615.19
_223
100 1 _aNiazi, Sarfaraz,
_d1949-
245 1 0 _aHandbook of Pharmaceutical Manufacturing Formulations.
_nVolume Three,
_pLiquid Products.
250 _aThird edition.
260 _aMilton :
_bCRC Press LLC,
_c2019.
300 _a1 online resource (457 p.)
500 _aDescription based upon print version of record.
520 _aThe Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume Three, Liquid Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, thisthirdvolume of a six-volume set, compiles data from FDA and EMA new drug applications, patents and patent applications, and other sources of generic and proprietary formulations including author's own experience, to cover the broad spectrum of cGMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent. Features: Largest source of authoritative and practical formulations, cGMP compliance guidance and self-audit suggestions Differs from other publications on formulation science in that it focuses on readily scalable commercial formulations that can be adopted for cGMP manufacturing Tackles common difficulties in formulating drugs and presents details on stability testing, bioequivalence testing, and full compliance with drug product safety elements Written by a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines
588 _aOCLC-licensed vendor bibliographic record.
650 7 _aMEDICAL / Pharmacology
_2bisacsh
650 0 _aDrugs
_xDosage forms.
856 4 0 _3Taylor & Francis
_uhttps://www.taylorfrancis.com/books/9781315102917
856 4 2 _3OCLC metadata license agreement
_uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
999 _c126811
_d126811